000286086 001__ 286086
000286086 005__ 20260413113805.0
000286086 0247_ $$2doi$$a10.14814/phy2.70845
000286086 0247_ $$2pmid$$apmid:41954020
000286086 0247_ $$2pmc$$apmc:PMC13062934
000286086 037__ $$aDZNE-2026-00382
000286086 041__ $$aEnglish
000286086 082__ $$a610
000286086 1001_ $$00000-0001-5137-7228$$aStreckfuss-Bömeke, Katrin$$b0
000286086 245__ $$aModels of the human heart for biomedical research: Opportunities and challenges.
000286086 260__ $$a[Erscheinungsort nicht ermittelbar]$$bWiley$$c2026
000286086 3367_ $$2DRIVER$$aarticle
000286086 3367_ $$2DataCite$$aOutput Types/Journal article
000286086 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1776073044_12975$$xReview Article
000286086 3367_ $$2BibTeX$$aARTICLE
000286086 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286086 3367_ $$00$$2EndNote$$aJournal Article
000286086 520__ $$aModel systems that mimic human cardiac structure and function are essential for the development of novel diagnostics and effective treatments for cardiovascular diseases. While non-human vertebrate models, from zebrafish to pig, remain vital to cardiovascular research, the translatability of findings to human patients is often limited. Therefore, animal experiments should be supplemented with human model systems, including human induced pluripotent stem cell-derived cells, 3D engineered constructs, and last but not least, native tissue preparations and isolated primary cardiomyocytes. However, while human myocardium remains the gold standard, human heart tissue - and particularly tissue from control hearts-remains scarce, and its use in research is generally restricted to settings where tissue has been excised from diseased or failing hearts. While it is in principle possible to use tissue from rejected non-failing donor hearts that cannot be transplanted, legal hurdles (e.g., in Germany) can restrict the use of non-transplanted donor organs in research. Given the challenges associated with accessing and using human tissue in biomedical research, an integrated strategy towards combining non-human vertebrate models, in silico models, and human tissue-derived models is recommended, enhancing the chances of successful research and development, and helping bridge the gap between preclinical and clinical research.
000286086 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000286086 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000286086 650_7 $$2Other$$aanimal models
000286086 650_7 $$2Other$$adonor tissue
000286086 650_7 $$2Other$$ahuman myocardium
000286086 650_7 $$2Other$$astem cell models
000286086 650_7 $$2Other$$avertebrate models
000286086 650_2 $$2MeSH$$aHumans
000286086 650_2 $$2MeSH$$aBiomedical Research: methods
000286086 650_2 $$2MeSH$$aAnimals
000286086 650_2 $$2MeSH$$aHeart: physiology
000286086 650_2 $$2MeSH$$aMyocytes, Cardiac
000286086 650_2 $$2MeSH$$aInduced Pluripotent Stem Cells
000286086 7001_ $$00000-0002-9001-0346$$aZelarayán, Laura C$$b1
000286086 7001_ $$00000-0001-7170-9509$$aSchnabel, Renate B$$b2
000286086 7001_ $$00000-0002-9363-1770$$aKränkel, Nicolle$$b3
000286086 7001_ $$00000-0003-3694-4559$$aMaack, Christoph$$b4
000286086 7001_ $$00000-0003-1750-1170$$aEschenhagen, Thomas$$b5
000286086 7001_ $$00000-0002-8615-6561$$aKappler, Hannah E$$b6
000286086 7001_ $$00000-0001-9845-3099$$aKlingmüller, Ursula$$b7
000286086 7001_ $$00000-0003-4048-6351$$aKramann, Rafael$$b8
000286086 7001_ $$00000-0002-2487-4744$$aLoewe, Axel$$b9
000286086 7001_ $$00000-0001-9722-0007$$aMilting, Hendrik$$b10
000286086 7001_ $$00000-0003-3094-1568$$aMolina, Cristina E$$b11
000286086 7001_ $$00000-0002-8739-6225$$aPanáková, Daniela$$b12
000286086 7001_ $$00000-0002-4641-7202$$aPodesser, Bruno K$$b13
000286086 7001_ $$00000-0002-5761-9635$$aSchnieke, Angelika$$b14
000286086 7001_ $$00000-0002-3099-526X$$aSchröder, Katrin$$b15
000286086 7001_ $$00000-0002-3127-1693$$aSeidel, Thomas$$b16
000286086 7001_ $$00000-0001-8034-2673$$aSossalla, Samuel$$b17
000286086 7001_ $$00000-0002-6773-9884$$aZgierski-Johnston, Callum$$b18
000286086 7001_ $$0P:(DE-2719)9001434$$aZimmermann, Wolfram-Hubertus$$b19
000286086 7001_ $$00000-0002-3295-4728$$aRog-Zielinska, Eva A$$b20
000286086 7001_ $$00000-0003-0416-6270$$aKohl, Peter$$b21
000286086 773__ $$0PERI:(DE-600)2724325-4$$a10.14814/phy2.70845$$gVol. 14, no. 7, p. e70845$$n7$$pe70845$$tPhysiological reports$$v14$$x2051-817X$$y2026
000286086 8564_ $$uhttps://pub.dzne.de/record/286086/files/DZNE-2026-00382.pdf$$yRestricted
000286086 8564_ $$uhttps://pub.dzne.de/record/286086/files/DZNE-2026-00382.pdf?subformat=pdfa$$xpdfa$$yRestricted
000286086 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001434$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b19$$kDZNE
000286086 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000286086 9141_ $$y2026
000286086 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-05$$wger
000286086 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPHYSIOL REP : 2022$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-08-08T17:09:21Z
000286086 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-08-08T17:09:21Z
000286086 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2024-08-08T17:09:21Z
000286086 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-08-08T17:09:21Z
000286086 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-05
000286086 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-05
000286086 9201_ $$0I:(DE-2719)1410002$$kAG Fischer$$lEpigenetics and Systems Medicine in Neurodegenerative Diseases$$x0
000286086 980__ $$ajournal
000286086 980__ $$aEDITORS
000286086 980__ $$aVDBINPRINT
000286086 980__ $$aI:(DE-2719)1410002
000286086 980__ $$aUNRESTRICTED